Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| InspireMD, Inc.NSPR · Entity 7318 | Director | September 21, 2026 | September 23, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
InspireMD, Inc.
Report date September 21, 2026 · Filed September 23, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series J Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.38 | IndirectSee Footnote | 30,624 |
Reported balance
After 2026-09-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-18 · Other · Disposed 30,625 · Balance 30,624 F1: See Exhibit 99.1; Note 1 F2: See Exhibit 99.1; Note 2 F3: See Exhibit 99.1; Note 3 |
| Series J Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.77 | IndirectSee Footnote | 30,625 |
Reported balance
After 2026-09-18 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-18 · Other · Acquired 30,625 · Balance 30,625 F1: See Exhibit 99.1; Note 1 F4: See Exhibit 99.1; Note 4 F3: See Exhibit 99.1; Note 3 |
| Series K Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.38 | IndirectSee Footnote | 0 |
Reported balance
After 2026-09-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-18 · Other · Disposed 61,248 · Balance 0 F5: See Exhibit 99.1; Note 5 F6: See Exhibit 99.1; Note 6 F3: See Exhibit 99.1; Note 3 |
| Series K Warrant (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.77 | IndirectSee Footnote | 61,248 |
Reported balance
After 2026-09-18 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-18 · Other · Acquired 61,248 · Balance 61,248 F5: See Exhibit 99.1; Note 5 F7: See Exhibit 99.1; Note 7 F3: See Exhibit 99.1; Note 3 |
Filing footnotes · ownership attribution and instrument terms
F1: See Exhibit 99.1; Note 1
F2: See Exhibit 99.1; Note 2
F3: See Exhibit 99.1; Note 3
F4: See Exhibit 99.1; Note 4
F5: See Exhibit 99.1; Note 5
F6: See Exhibit 99.1; Note 6
F7: See Exhibit 99.1; Note 7
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 18, 2026 Filed Sep 23, 2026 20:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherSeries K Warrant (right to buy) · Derivative | 61,248 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001493152-26-043916 · ownership.xml · derivative · entry 4 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 61,248 Underlying: Common Stock · 61,248 shares Expires not disclosed F5 · kind: See Exhibit 99.1; Note 5 F7 · derivative.expiration_date: See Exhibit 99.1; Note 7 F3 · ownership.direct: See Exhibit 99.1; Note 3 Read SEC document |
| September 18, 2026 Filed Sep 23, 2026 20:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherSeries K Warrant (right to buy) · Derivative | 61,248 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001493152-26-043916 · ownership.xml · derivative · entry 3 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 61,248 shares Expires not disclosed F5 · kind: See Exhibit 99.1; Note 5 F6 · derivative.expiration_date: See Exhibit 99.1; Note 6 F3 · ownership.direct: See Exhibit 99.1; Note 3 Read SEC document |
| September 18, 2026 Filed Sep 23, 2026 20:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherSeries J Warrant (right to buy) · Derivative | 30,625 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001493152-26-043916 · ownership.xml · derivative · entry 2 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 30,625 Underlying: Common Stock · 30,625 shares Expires not disclosed F1 · kind: See Exhibit 99.1; Note 1 F4 · derivative.expiration_date: See Exhibit 99.1; Note 4 F3 · ownership.direct: See Exhibit 99.1; Note 3 Read SEC document |
| September 18, 2026 Filed Sep 23, 2026 20:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherSeries J Warrant (right to buy) · Derivative | 30,625 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001493152-26-043916 · ownership.xml · derivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 30,624 Underlying: Common Stock · 30,625 shares Expires not disclosed F1 · kind: See Exhibit 99.1; Note 1 F2 · derivative.expiration_date: See Exhibit 99.1; Note 2 F3 · ownership.direct: See Exhibit 99.1; Note 3 Read SEC document |
| January 14, 2026 Filed Jan 16, 2026 23:09 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 88,053 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-002662 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,586 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| June 29, 2025 Filed Jul 23, 2025 20:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherSeries I Warrant (right to buy) · Derivative | 61,248 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001641172-25-020695 · ownership.xml · derivative · entry 3 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 61,248 shares Expires 2025-07-23 F1 · ownership.nature: These securities are held by the Michael Berman Revocable Trust. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. Read SEC document |
| June 29, 2025 Filed Jul 23, 2025 20:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherCommon Stock | 61,248 | $1.38 | $84,687.61 |
DisclosureSEC source: 0001641172-25-020695 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 244,994 F1 · ownership.nature: These securities are held by the Michael Berman Revocable Trust. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 14,836 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001726 · ownership.xml · derivative · entry 3 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,950 Underlying: Common Stock · 14,836 shares Expires 2035-01-07 F3 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 32,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001726 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,533 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 07, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| June 24, 2024 Filed Jun 27, 2024 01:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherSeries H Warrant (right to buy) · Derivative | 61,249 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001493152-24-025340 · ownership.xml · derivative · entry 3 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 61,249 shares Expires 2024-06-26 F1 · ownership.nature: These securities are held by the Michael Berman Revocable Trust. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. Read SEC document |
| June 24, 2024 Filed Jun 27, 2024 01:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | OtherCommon Stock | 61,249 | $1.38 | $84,688.99 |
DisclosureSEC source: 0001493152-24-025340 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 183,746 F1 · ownership.nature: These securities are held by the Michael Berman Revocable Trust. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:52 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 11,098 | $0.00 Strike: $3.14 | $0.00 |
DisclosureSEC source: 0001493152-24-003774 · ownership.xml · derivative · entry 3 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,114 Underlying: Common Stock · 11,098 shares Expires 2034-01-23 F3 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service. Read SEC document |
| January 23, 2024 Filed Jan 25, 2024 21:52 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 29,032 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-003774 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 232,042 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 23, 2025 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| January 02, 2024 Filed Jan 11, 2024 21:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 3,782 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-002067 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,010 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended December 31, 2023. Read SEC document |
| October 02, 2023 Filed Oct 4, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 3,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-035644 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,228 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended September 30, 2023. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 4,351 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-023436 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 196,122 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended June 30, 2023. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 49,750 | $0.00 Strike: $1.76 | $0.00 |
DisclosureSEC source: 0001493152-23-018336 · ownership.xml · derivative · entry 3 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,016 Underlying: Common Stock · 49,750 shares Expires 2033-05-17 F3 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service. Read SEC document |
| May 17, 2023 Filed May 19, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 149,260 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-018336 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,087 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of May 17, 2024, May 17, 2025 and May 17, 2026, subject to the Reporting Person's continued service. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseSeries K Warrants to purchase Common Stock · Derivative | 61,248 | $1.63 Strike: $1.38 | $99,999.61 |
DisclosureSEC source: 0001493152-23-017789 · ownership.xml · derivative · entry 6 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 61,248 Underlying: Common Stock · 61,248 shares Expires not disclosed F10 · shares: The aggregate number of warrants reported in this row consists of 61,249 Series K Warrants that were acquired in the Private Placement. F2 · price: The purchase price per share of common stock and associated Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants in the Private Placement was $1.6327. F11 · derivative.expiration_date: The Series K Warrants have a term of the earlier of (i) May 15, 2028 and (ii) 20 trading days following the end of the fourth fiscal quarter after the fiscal quarter in which the first commercial sales of the CGuard Carotid Stent System in the United States begin. F3 · ownership.nature: These securities are held by the Michael Berman Revocable Trust. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseSeries J Warrants to purchase Common Stock · Derivative | 61,249 | $1.63 Strike: $1.38 | $100,001.24 |
DisclosureSEC source: 0001493152-23-017789 · ownership.xml · derivative · entry 5 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 61,249 Underlying: Common Stock · 61,249 shares Expires not disclosed F8 · shares: The aggregate number of warrants reported in this row consists of 61,249 Series J Warrants that were acquired in the Private Placement. F2 · price: The purchase price per share of common stock and associated Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants in the Private Placement was $1.6327. F9 · derivative.expiration_date: The Series J Warrants have a term of the earlier of (i) May 15, 2028 and (ii) 20 trading days following the Company's announcement of receipt of FDA approval for the SwitchGuard transcarotid system and CGuard Prime 80 cm. F3 · ownership.nature: These securities are held by the Michael Berman Revocable Trust. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseSeries I Warrants to purchase Common Stock · Derivative | 61,248 | $1.63 Strike: $1.38 | $99,999.61 |
DisclosureSEC source: 0001493152-23-017789 · ownership.xml · derivative · entry 4 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 61,248 Underlying: Common Stock · 61,248 shares Expires not disclosed F6 · shares: The aggregate number of warrants reported in this row consists of 61,248 Series I Warrants that were acquired in the Private Placement. F2 · price: The purchase price per share of common stock and associated Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants in the Private Placement was $1.6327. F7 · derivative.expiration_date: The Series I Warrants have a term of the earlier of (i) May 15, 2028 and (ii) 20 trading days following the Company's announcement of receipt of Premarket Approval (PMA) from the Food and Drug Administration ("FDA") for the CGuard Prime Carotid Stent System (135 cm). F3 · ownership.nature: These securities are held by the Michael Berman Revocable Trust. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseSeries H Warrants to purchase Common Stock · Derivative | 61,249 | $1.63 Strike: $1.38 | $100,001.24 |
DisclosureSEC source: 0001493152-23-017789 · ownership.xml · derivative · entry 3 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 61,249 Underlying: Common Stock · 61,249 shares Expires not disclosed F4 · shares: The aggregate number of warrants reported in this row consists of 61,249 Series H Warrants that were acquired in the Private Placement. F2 · price: The purchase price per share of common stock and associated Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants in the Private Placement was $1.6327. F5 · derivative.expiration_date: The Series H Warrants have a term of the earlier of (i) May 15, 2028 and (ii) 20 trading days following the Company's public release of primary and secondary end points related to one year follow up study results from the Company's C-Guardians pivotal trial. F3 · ownership.nature: These securities are held by the Michael Berman Revocable Trust. Read SEC document |
| May 12, 2023 Filed May 16, 2023 20:15 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 122,497 | $1.63 | $200,000.85 |
DisclosureSEC source: 0001493152-23-017789 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 122,497 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on May 12, 2023 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement"). F2 · price: The purchase price per share of common stock and associated Series H Warrants, Series I Warrants, Series J Warrants and Series K Warrants in the Private Placement was $1.6327. F3 · ownership.nature: These securities are held by the Michael Berman Revocable Trust. Read SEC document |
| April 01, 2023 Filed Apr 4, 2023 21:00 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 9,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-010852 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,827 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that are earned and vested upon grant and are issued in lieu of cash compensation in connection with the Reporting Person's service on the Issuer's Board of Directors for the quarter ended March 31, 2023. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 5,749 | $0.00 Strike: $4.09 | $0.00 |
DisclosureSEC source: 0001493152-21-028170 · ownership.xml · derivative · entry 2 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,749 Underlying: Common Stock · 5,749 shares Expires 2031-11-10 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:05 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 17,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-21-028170 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,336 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 12:11 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseWarrants · Derivative | 40,320 | $0.62 Strike: $0.68 | $24,998.40 |
DisclosureSEC source: 0001493152-21-003205 · ownership.xml · derivative · entry 2 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,320 Underlying: Common Stock · 40,320 shares Expires 2026-02-08 F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 80,640 shares of common stock and warrants to purchase 40,320 shares of common stock together, as part of 80,640 units, at a purchase price of $0.62 per unit. F1 · derivative.underlying_shares: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 80,640 shares of common stock and warrants to purchase 40,320 shares of common stock together, as part of 80,640 units, at a purchase price of $0.62 per unit. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 12:11 UTC | InspireMD, Inc. NSPR · Entity 7318 | PurchaseCommon Stock | 80,640 | $0.62 | $49,996.80 |
DisclosureSEC source: 0001493152-21-003205 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,275 F1 · kind: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 80,640 shares of common stock and warrants to purchase 40,320 shares of common stock together, as part of 80,640 units, at a purchase price of $0.62 per unit. F1 · balance_after: The Reporting Person purchased, in a follow-on underwritten public offering by the Issuer, 80,640 shares of common stock and warrants to purchase 40,320 shares of common stock together, as part of 80,640 units, at a purchase price of $0.62 per unit. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 17:00 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 52,678 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001493152-20-017129 · ownership.xml · derivative · entry 2 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,692 Underlying: Common Stock · 52,678 shares Expires 2030-08-31 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 17:00 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 158,033 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-20-017129 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,635 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service. Read SEC document |
| August 31, 2020 Filed Feb 10, 2021 12:11 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions to purchase common stock (right to buy) · Derivative | 52,678 | $0.00 Strike: $0.39 | $0.00 |
DisclosureSEC source: 0001493152-21-003205 · ownership.xml · derivative · entry 3 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,692 Underlying: Common Stock · 52,678 shares Expires 2030-08-31 F2 · security: No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. F3 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of August 31, 2021, August 31, 2022 and August 31, 2023, subject to the Reporting Person's continued service. Read SEC document |
| February 04, 2019 Filed Feb 6, 2019 21:30 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantCommon Stock | 130,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-001459 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,005 Read SEC document |
| December 07, 2016 Filed Dec 8, 2016 18:49 UTC | InspireMD, Inc. NSPR · Entity 7318 | GrantOptions (right to buy) · Derivative | 12,500 | $0.00 Strike: $3.04 | $0.00 |
DisclosureSEC source: 0001493152-16-015750 · form4.xml · derivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2026-12-07 F1 · derivative.exercise_date: The options vest in three equal annual installments, with 1/3 becoming exercisable on each of December 7, 2017, December 7, 2018 and December 7, 2019, subject to Mr. Berman's continued service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.